Mangalam Drugs and Organics Limited is strengthening its board with the appointment of Prabhakar Raghunath Zavar as a Non-Executive Independent Director, effective September 15, 2026. The move, approved by the board and awaiting shareholder confirmation at the forthcoming Extraordinary General Meeting, marks another step in governance strengthening for the company. Zavar is slated to serve a five-year term, bringing a seasoned voice to the independent director’s chair as the company navigates its growth trajectory.
Zavar comes with a long career span highlighted by his expertise in accounts, finance and taxation. Holding a Bachelor of Commerce in Accounting from Mumbai University, he has built over 38 years of professional experience, including significant exposure to export-oriented businesses and professional services across a diversified client base. The appointment notes that he is not related to any of the company’s directors, underscoring the independence expected of the role.
The appointment was placed on record following a Nomination and Remuneration Committee recommendation and was communicated in connection with a postal ballot process conducted in late 2026. The scrutiny report confirms the resolution for appointing Zavar as an Independent Director was passed, reflecting strong support from shareholders via remote e-voting. The company indicated the voting results would be published on its website alongside the scrutinizer’s report, with the process overseen by a designated scrutineer and mediation witnesses as required under applicable rules.
Industry observers view such board-level appointments as an important signal of Mangalam’s ongoing emphasis on governance, risk management and strategic oversight. With Zavar’s background in accounting and finance, the board gains a complementary perspective that could support financial discipline, regulatory compliance and enhanced stakeholder accountability as the company pursues its growth and value creation agenda.